1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Esclerosis Múltiple

Esclerosis Múltiple

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Domínguez-Mozo MI, González-Suárez I, Villar LM, Costa-Frossard L, Villarrubia N, Aladro Y, Pilo B, Montalbán X, Comabella M, Casanova-Peño I, Martínez-Ginés ML, García-Domínguez JM, García-Martínez MÁ, Arroyo R, Álvarez-Lafuente R.

    Teriflunomide and Epstein-Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response

    Frontiers in immunology . 14: 1248182-1248182. Nº de citas: 4

    [doi:10.3389/fimmu.2023.1248182]

  • Llufriu S, Agüera E, Costa-Frossard L, Galán V, Landete L, Lourido D, Meca-Lallana JE, Moral E, Bravo-Rodríguez F, Koren L, Labiano A, León A, Martín P, Monedero MD, Requeni L, Zubizarreta I, Rovira À.

    Recommendations for the coordination of Neurology and Neuroradiology Departments in the management of patients with multiple sclerosis.

    Neurologia . 38(7): 453-462.

    [doi:10.1016/j.nrleng.2021.01.009]

  • Rodero-Romero A, Sainz de la Maza S, Fernández-Velasco JI, Monreal E, Walo-Delgado PE, Chico-García JL, Villarrubia N, Rodríguez-Jorge F, Rodríguez-Ramos R, Masjuan J, Costa-Frossard L, Villar LM.

    Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine.

    Vaccines . 11(9): .

    [doi:10.3390/vaccines11091399]

  • Labiano-Fontcuberta A, Costa-Frossard L, Sainz de la Maza S, Rodríguez-Jorge F, Chico-García JL, González PN, Monreal E.

    Predictive models of multiple sclerosis-related cognitive performance using routine clinical practice predictors

    MULTIPLE SCLEROSIS AND RELATED DISORDERS . 76: 104849-104849. Nº de citas: 4

    [doi:10.1016/j.msard.2023.104849]

  • Fissolo N, Calvo-Barreiro L, Eixarch H, Boschert U, Villar LM, Costa-Frossard L, Ferrer M, Sanchez A, Borràs E, Sabidó E, Espejo C, Montalban X, Comabella M.

    Molecular signature associated with cladribine treatment in patients with multiple sclerosis.

    Frontiers in immunology . 14: 1233546-1233546. Nº de citas: 4

    [doi:10.3389/fimmu.2023.1233546]

  • Fernández O, Montalban X, Agüera E, Aladro Y, Alonso A, Arroyo R, Brieva L, Calles C, Costa-Frossard L, Eichau S, García-Domínguez JM, Hernández MA, Landete L, Llaneza M, Llufriu S, Meca-Lallana JE, Meca-Lallana V, Mongay-Ochoa N, Moral E, Oreja-Guevara C, Ramió-Torrentà L, Téllez N, Romero-Pinel L, Rodríguez-Antigüedad A.

    15th Post-ECTRIMS Meeting: a review of the latest developments presented at the 2022 ECTRIMS Congress (Part II)

    REVISTA DE NEUROLOGIA . 77(2): 47-60.

    [doi:10.33588/rn.7702.2023168]

  • Fernández O, Montalban X, Agüera E, Aladro Y, Alonso A, Arroyo R, Brieva L, Calles C, Costa-Frossard L, Eichau S, García-Domínguez JM, Hernández MA, Landete L, Llaneza M, Llufriu S, Meca-Lallana JE, Meca-Lallana V, Mongay-Ochoa N, Moral E, Oreja-Guevara C, Ramió-Torrentà L, Téllez N, Romero-Pinel L, Rodríguez-Antigüedad A.

    15th Post-ECTRIMS Meeting: a review of the latest developments presented at the 2022 ECTRIMS Congress (Part I)

    REVISTA DE NEUROLOGIA . 77(1): 19-30.

    [doi:10.33588/rn.7701.2023167]

  • Ros Castelló V, Sánchez Sánchez A, Natera Villalba E, Gómez López A, Parra P, Rodríguez Jorge F, Buisán Catevilla J, García Barragán N, Masjuan J, Corral I.

    Spinal cord infarction: aetiology, imaging findings, and prognostic factors in a series of 41 patients.

    Neurologia . 38(6): 391-398. Nº de citas: 3

    [doi:10.1016/j.nrleng.2020.11.004]

  • Loarce-Martos J, Calvo Sanz L, Garrote-Corral S, Ballester González R, Pariente Rodríguez R, Rita CG, García-Soidan A, Bachiller-Corral J, Roy Ariño G.

    Myositis autoantibodies detected by line blot immunoassay: clinical associations and correlation with antibody signal intensity.

    RHEUMATOLOGY INTERNATIONAL . 43(6): 1101-1109. Nº de citas: 11

    [doi:10.1007/s00296-023-05279-5]

  • Núñez C, Carrasco A, Corzo M, Pariente R, Esteve M, Roy G.

    Flow cytometric analysis of duodenal intraepithelial lymphocytes (celiac lymphogram): A diagnostic test for celiac disease.

    Methods in cell biology . 179: 143-155. Nº de citas: 4

    [doi:10.1016/bs.mcb.2022.11.004]

  • Malhotra S, Hurtado-Navarro L, Pappolla A, Villar LMM, Río J, Montalban X, Pelegrin P, Comabella M.

    Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure.

    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION . 10(3): . Nº de citas: 18

    [doi:10.1212/NXI.0000000000200100]

  • Sainz de la Maza S, Walo-Delgado PE, Rodríguez-Domínguez M, Monreal E, Rodero-Romero A, Chico-García JL, Pariente R, Rodríguez-Jorge F, Ballester-González R, Villarrubia N, Romero-Hernández B, Masjuan J, Costa-Frossard L, Villar LM.

    Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies.

    Vaccines . 11(4): . Nº de citas: 6

    [doi:10.3390/vaccines11040786]

  • Sainz de la Maza S, Gómez-Ballesteros R, Borges M, Martín-Martínez J, Sotoca J, Alonso A, Caminero AB, Borrega L, Sánchez-Menoyo JL, Barrero-Hernández FJ, Calles C, Brieva L, Blasco-Quílez MR, Dotor García-Soto J, Del Campo-Amigo M, Navarro-Cantó L, Agüera E, Garcés-Redondo M, Carmona O, Gabaldón-Torres L, Forero L, Hervàs M, Medrano N, Maurino J, Castillo-Triviño T.

    Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach

    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL . 9(2): . Nº de citas: 1

    [doi:10.1177/20552173231169475]

  • Núñez-Torrón Stock C, Jiménez Chillón C, Martín Moro F, Marquet Palomanes J, Velázquez Kennedy K, Piris Villaespesa M, Roldán Santiago E, Rodríguez Martín E, Chinea Rodríguez A, García Gutiérrez V, Moreno Jiménez G, López Jiménez J, Herrera Puente P.

    Patients with secondary acute myeloid leukemia undergoing allogeneic stem-cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry.

    HEMATOLOGICAL ONCOLOGY . 41: 753-761. Nº de citas: 5

    [doi:10.1002/hon.3160]

  • Monreal E, Fernández-Velasco JI, García-Sánchez MI, Sainz de la Maza S, Llufriu S, Álvarez-Lafuente R, Casanova B, Comabella M, Ramió-Torrentà L, Martínez-Rodríguez JE, Brieva L, Saiz A, Eichau S, Cabrera-Maqueda JM, Villarrubia N, Espiño M, Pérez-Miralles F, Montalbán X, Tintoré M, Quiroga-Varela A, Domínguez-Mozo MI, Rodríguez-Jorge F, Chico-García JL, Lourido D, Álvarez-Cermeño JC, Masjuan J, Costa-Frossard L, Villar LM.

    Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs

    JAMA NEUROLOGY . 80(4): 397-403. Nº de citas: 32

    [doi:10.1001/jamaneurol.2023.0010]

  • Gascón-Giménez F, Alcalá C, Ramió-Torrentà L, Montero P, Matías-Guiu J, Gómez-Esteve I, Oreja-Guevara C, Gil-Perotín S, Blanco Y, Carcelén M, Quintanilla-Bordás C, Costa L.

    Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience.

    Frontiers in Neurology . 14: 1060696-1060696. Nº de citas: 2

    [doi:10.3389/fneur.2023.1060696]

  • Giraldo-Tugores M, Vaquero-Rey A, Santacruz-Santos M, Rodríguez-Martín E, de Andrés A, Ballester-González R, Barra-Castro A, Fernández-Lozano C, Martínez-Botas J, Antolín-Amérigo D.

    Application of different in vitro tests for the precise diagnosis of double sensitization to Vespula-Polistes.

    Journal of investigational allergology & clinical immunology . 33(5): 0-0. Nº de citas: 1

    [doi:10.18176/jiaci.0890]

  • Hegen H, Arrambide G, Gnanapavan S, Kaplan B, Khalil M, Saadeh R, Teunissen C, Tumani H, Villar LM, Willrich MAV, Zetterberg H, Deisenhammer F.

    Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement

    MULTIPLE SCLEROSIS JOURNAL . 29(2): 182-195. Nº de citas: 37

    [doi:10.1177/13524585221134217]